tradingkey.logo
tradingkey.logo

MBX Biosciences Inc

MBX
28.500USD
+0.210+0.74%
Close 03/27, 16:00ETQuotes delayed by 15 min
1.28BMarket Cap
LossP/E TTM
You can check out the annual or quarterly balance sheets of MBX Biosciences Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
Total equity
Cash, cash equivalents and short-term investments
42.55%373.70M
41.37%391.67M
306.98%224.91M
242.43%240.79M
--262.15M
--277.06M
--55.26M
--70.32M
- Cash and cash equivalents
52.56%75.29M
67.93%223.13M
218.17%39.78M
-15.59%29.90M
--49.35M
--132.87M
--12.50M
--35.42M
-Short-term investments
40.23%298.42M
16.89%168.55M
332.95%185.13M
504.41%210.88M
--212.80M
--144.20M
--42.76M
--34.89M
Receivables
210.85%2.12M
80.42%1.55M
412.80%841.00K
595.98%1.39M
--682.00K
--858.00K
--164.00K
--199.00K
-Loans receivable
--2.12M
--1.55M
--841.00K
--1.39M
----
----
----
----
-Other receivables
----
----
----
----
--682.00K
--858.00K
--164.00K
--199.00K
Prepaid expenses
32.89%4.85M
40.98%3.40M
-5.17%2.97M
-26.56%1.48M
--3.65M
--2.41M
--3.13M
--2.01M
Other current assets
7.22%861.00K
5.25%882.00K
95.04%472.00K
272.62%626.00K
--803.00K
--838.00K
--242.00K
--168.00K
Total current assets
42.75%381.54M
41.37%397.50M
289.77%229.19M
236.02%244.28M
--267.29M
--281.17M
--58.80M
--72.70M
Non-current assets
Net Fixed Assets
168.72%3.22M
113.90%2.52M
78.34%2.28M
81.82%1.60M
--1.20M
--1.18M
--1.28M
--880.00K
-Fixed Assets
140.10%3.89M
102.98%3.13M
81.19%2.84M
89.78%2.10M
--1.62M
--1.54M
--1.57M
--1.11M
-Accumulated depreciation
58.77%670.00K
67.58%610.00K
93.77%560.00K
120.80%499.00K
--422.00K
--364.00K
--289.00K
--226.00K
Other non-current assets
666.00%383.00K
0.00%50.00K
-98.18%51.00K
-97.13%50.00K
--50.00K
--50.00K
--2.80M
--1.74M
Total non-current assets
188.63%3.60M
109.27%2.57M
-42.86%2.33M
-37.09%1.65M
--1.25M
--1.23M
--4.08M
--2.62M
Total assets
43.42%385.14M
41.67%400.08M
268.18%231.52M
226.51%245.93M
--268.54M
--282.40M
--62.88M
--75.32M
Liabilities
Current liabilities
-Other payables
--0.00
--0.00
--0.00
--0.00
----
----
----
----
Accrued expenses
122.65%12.35M
41.52%8.14M
21.58%5.85M
160.61%6.11M
--5.54M
--5.75M
--4.81M
--2.34M
Other current liabilities
--0.00
--0.00
--0.00
--0.00
----
----
----
----
Total current liabilities
40.21%15.49M
10.46%12.06M
43.40%11.76M
84.01%10.48M
--11.05M
--10.92M
--8.20M
--5.70M
Non-current liabilities
Long-term debt and lease liabilities
--424.00K
965.91%469.00K
488.51%512.00K
-100.00%0.00
--0.00
--44.00K
--87.00K
--129.00K
-Long-term lease liabilities
--424.00K
965.91%469.00K
488.51%512.00K
----
--0.00
--44.00K
--87.00K
--129.00K
Other non-current liabilities
-95.24%2.00K
-89.71%7.00K
-88.00%15.00K
-87.57%23.00K
--42.00K
--68.00K
--125.00K
--185.00K
Total non-current liabilities
914.29%426.00K
325.00%476.00K
148.58%527.00K
-92.68%23.00K
--42.00K
--112.00K
--212.00K
--314.00K
Total liabilities
43.52%15.92M
13.65%12.54M
46.05%12.28M
74.78%10.50M
--11.09M
--11.03M
--8.41M
--6.01M
Shareholders' equity
Common equity
50.27%593.41M
50.01%589.80M
6672.03%400.02M
8036.87%396.75M
--394.89M
--393.18M
--5.91M
--4.88M
Preferred equity
----
----
----
----
----
----
--152.36M
--152.36M
Retained earnings
-63.25%-224.48M
-66.02%-202.41M
-74.22%-180.80M
-83.56%-161.38M
---137.50M
---121.92M
---103.78M
---87.92M
Capital reserves
50.27%593.41M
50.01%589.79M
6674.24%400.02M
8038.44%396.75M
--394.89M
--393.18M
--5.91M
--4.88M
Gains losses not affecting retained earnings
420.00%286.00K
45.28%154.00K
173.33%11.00K
1866.67%53.00K
--55.00K
--106.00K
---15.00K
---3.00K
Total equity
43.42%369.22M
42.81%387.54M
302.48%219.24M
239.67%235.42M
--257.44M
--271.37M
--54.47M
--69.31M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--

FAQs

What is the balance sheet?

It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.
KeyAI